newsfilter
← Latest News
PR Newswire·

CASI PHARMACEUTICALS COMPLETES REDOMICILIATION MERGER

BEIJING, March 21, 2023 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (NASDAQ:CASI) ("CASI" or the "Company"), a biopharmaceutical company focused on developing and commercializing innovative therapeutics